secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rani Therapeutics Holdings, Inc. (RANI)
CIK:        0001856725
Form:       8-K
Filed at:   2025-04-30T23:59:59+00:00
Accession:  0000950170-25-060586
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Director Laureen DeBuono retires from Rani Therapeutics board; committees reconstituted
--------------------------------------------------------------------------------

- Laureen DeBuono resigned from Board effective April 24, 2025; no disagreement with company.
- Board reconstituted Audit Committee: Rometty (Chair), Butel, Nanavaty; Compensation: Nanavaty (Chair), Ausiello.
- Nominating and Governance Committee: Butel (Chair), Ausiello, Rometty.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1856725/000095017025060586/0000950170-25-060586-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1856725/000095017025060586/rani-20250424.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-060586

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer